Faculty

• 

• Christopher B. Granger, MD

  Professor of Medicine
  Director
  Cardiac Intensive Care Unit
  Duke University Medical Center
  Durham, North Carolina, United States

  Disclosures

  Disclosure: Christopher B. Granger, MD, has disclosed the following relevant financial relationships:
  Served as an advisor or consultant for: AbbVie, Inc.; AstraZeneca; Bayer AG; Boehringer Ingelheim Pharmaceuticals, Inc.; Boston Scientific; Bristol Myers Squibb Company; Espero BioPharma; Janssen Pharmaceuticals; Medtronic, Inc.; Merck & Co., Inc.; Novo Nordisk; Novartis Pharmaceutical Company; Pfizer, Inc.; Roche Diagnostics
  Received grants for clinical research from: AKROS Pharma, Inc.; Apple; AstraZeneca; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol Myers Squibb Company; Daiichi Sankyo, Inc.; Duke Clinical Research Institute; GlaxoSmithKline; Janssen Pharmaceuticals; Medtronic, Inc.; Novartis Pharmaceuticals Corporation; Pfizer, Inc.

• 

• Gregory Y.H. Lip, MD

  Price-Evans Chair of Cardiovascular Medicine
  University of Liverpool
  Director, Liverpool Centre for Cardiovascular Science
  Liverpool Heart & Chest Hospital Centre for Cardiovascular Sciences
  Liverpool, United Kingdom

  Disclosures

  Disclosure: Gregory Y.H. Lip, MD, has disclosed the following relevant financial relationships:
  Served as an advisor or consultant for: Bayer AG; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol-Myers Squibb Company; Daiichi-Sankyo, Inc.; Janssen Pharmaceuticals; Medtronic, Inc.; Novartis Pharmaceuticals Corporation; Pfizer, Inc.; Verseon
  Served as a speaker or a member of a speakers bureau for: Bayer AG; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol-Myers Squibb Company; Daiichi-Sankyo, Inc.; Medtronic, Inc.; Pfizer, Inc.

• 

• Roxana Mehran, MD

  Professor of Medicine (Cardiology)
  Icahn School of Medicine
  Mount Sinai
  New York, New York, United States

  Disclosures

  Disclosure: Roxana Mehran, MD, has disclosed the following relevant financial relationships:
  Served as an advisor or consultant for: ABIOMED; Abbott, Inc.; Boston Scientific; Regeneron Pharmaceuticals, Inc.; Roivant Sciences, Inc.; Sanofi; Siemens AG; Spectranetics; Philips Healthcare; The Medicines Company; Volcano Corporation
  Received grants for clinical research from: AstraZeneca; Bayer AG; Beth Israel Deaconess; Bristol-Myers Squibb Company; CSL Behring; Daiichi Sankyo, Inc.; Eli Lilly and Company; Medtronic, Inc.; Novartis Pharmaceuticals Corporation; OrbusNeich; Sanofi
  Owns stock, stock options, or bonds from: Claret Medical, Inc.; Elixir Medical
  Other: Bristol Myers Squibb Company; Janssen Pharmaceuticals; Novartis Pharmaceuticals Corporation; Watermark Research

• 

• Renato D. Lopes, MD, PhD

  Professor of Medicine
  Duke Clinical Research Institute
  Duke University School of Medicine
  Durham, North Carolina, United States

  Disclosures

  Disclosure: Renato D. Lopes, MD, PhD, has disclosed the following relevant financial relationships:
  Served as an advisor or consultant for: Bayer AG; Boehringer Ingleheim Pharmaceuticals, Inc.; Bristol-Myers Squibb Company; GlaxoSmithKline; Pfizer, Inc.; Portola Pharmaceuticals, Inc.
  Received grants for clinical research from: Amgen, Inc.; Bayer AG; Boehringer Ingleheim Pharmaceuticals Corporation; Bristol-Myers Squibb Company; GlaxoSmithKline; Pfizer, Inc.; Portola Pharmaceuticals, Inc.; Sanofi-Aventis

Editor

• Anne M. Sendaydiego, PharmD

  Scientific Director, WebMD Global, LLC

  Disclosures

  Anne M. Sendaydiego, PharmD, has disclosed no relevant financial relationships.

Content Reviewer

• Nafeez Zawahir, MD

  CME Clinical Director

  Disclosures

  Disclosure: Nafeez Zawahir, MD, has disclosed no relevant financial relationships.